Sigma Planning Corp Sells 1,001 Shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Sigma Planning Corp decreased its stake in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) by 18.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,548 shares of the company’s stock after selling 1,001 shares during the period. Sigma Planning Corp owned approximately 0.07% of Invesco Dynamic Pharmaceuticals ETF worth $274,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of PJP. Cetera Advisors LLC bought a new stake in shares of Invesco Dynamic Pharmaceuticals ETF during the first quarter worth $28,000. Patriot Financial Group Insurance Agency LLC grew its position in Invesco Dynamic Pharmaceuticals ETF by 58.4% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 442 shares of the company’s stock valued at $29,000 after purchasing an additional 163 shares in the last quarter. Hanson McClain Inc. bought a new position in Invesco Dynamic Pharmaceuticals ETF in the second quarter valued at $30,000. Liberty Wealth Management LLC grew its position in Invesco Dynamic Pharmaceuticals ETF by 69.0% in the second quarter. Liberty Wealth Management LLC now owns 779 shares of the company’s stock valued at $47,000 after purchasing an additional 318 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC bought a new position in Invesco Dynamic Pharmaceuticals ETF in the second quarter valued at $72,000.

Invesco Dynamic Pharmaceuticals ETF stock opened at $57.31 on Thursday. Invesco Dynamic Pharmaceuticals ETF has a 1-year low of $55.27 and a 1-year high of $74.29. The company has a fifty day simple moving average of $57.96 and a 200 day simple moving average of $61.85.

About Invesco Dynamic Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

See Also: Understanding Average Daily Trade Volume

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP).

Institutional Ownership by Quarter for Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Dynamic Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.